Clinical Trials Logo

Tennis Elbow clinical trials

View clinical trials related to Tennis Elbow.

Filter by:

NCT ID: NCT06342518 Completed - Clinical trials for Lateral Epicondylitis

ESWT in Lateral Epicondylitis: Clinical,Ultrasonographic Evaluation

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This study aimed to check and compare how well shock wave therapy works for tennis elbow, both in terms of symptoms and what we can see on ultrasound.

NCT ID: NCT06317545 Recruiting - Clinical trials for Lateral Epicondylitis

Effects of Nerchal Exercises on Lateral Epicondylitis.

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Painful condition of lateral epicondyle of the humerus characterized by the inflammation of the tendons during loading of the wrist extensor muscles is a common musculoskeletal presentation in men and women between 35 and 54 years of age. The above symptom is associated with a clinical diagnosis of lateral elbow tendinopathy (LET), also known as tennis elbow or lateral epicondylalgia the two effective treatment approaches for lateral epicondylitis are Nirschl exercises and Mulligan taping. This study aims to evaluate the effectiveness of Nirschl exercises with or without Mulligan taping in treating lateral epicondylitis. The study design for this project employs a randomized controlled trial and a sample of individuals with lateral epicondylitis randomly assigned in one of the two groups i.e., Nirschl exercises only and Nirschl exercises with Mulligan taping. Nirschl exercises involve the eccentric strengthening of the wrist extensor muscles and forearm. The participants in both groups will receive Nirschl exercises while the second group will also receive Mulligan taping, which involves the application of tape to the lateral aspect of the elbow to offload stress during movement of the extensor tendons. Different outcome measures including pain intensity, functional disability, grip strength, range of motion will be evaluated using, PRTEE Scale, Visual Analogue Scale (VAS) and Calibrated Jammer hand held dynamometer. Statistical analysis, including independent t-tests or chi-square tests, will be conducted to compare the outcomes between the two groups. The significance level will be set at p < 0.05. This study will contribute to the evidence base regarding the efficacy of Nirschl exercises and Mulligan taping in managing lateral epicondylitis and will help the clinicians and patients in deciding the best treatment approach for lateral epicondylitis.

NCT ID: NCT06301152 Completed - Clinical trials for Lateral Epicondylitis

Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objectives: This study aims to evaluate and compare the short-term efficacy of high-intensity laser therapy (HILT) and extra corporeal shock wave therapy(ESWT) on pain, sensitivity, handgrip strength, and functions in the treatment of lateral epicondylitis (LE). Material and methods: Forty five participants (age range, 18 to 65 years) with unilateral elbow pain were randomized into two groups. HILT group (n = 22) and the ESWT group (n = 23). The HILT and ESWT were administered three times a week for three weeks, and each treatment was combined with exercises. All patients in both groups were evaluated with ultrasonography for common extensor tendon(CET) thickness. A visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QDASH), and hand grip strength test were used to evaluate the patients before, one, and six weeks after treatment.

NCT ID: NCT06300749 Completed - Clinical trials for Lateral Epicondylitis

Effectiveness of Chiropractic Cervical Manipulation in Lateral Epicondylitis

Start date: October 30, 2018
Phase: N/A
Study type: Interventional

İt is aimed to examine the effect of chiropractic cervical manipulation on pain, functionality and grip strength in patients with lateral epicondylitis and whether it is preferable to placebo.

NCT ID: NCT06271915 Recruiting - Clinical trials for Lateral Epicondylitis

Role of Cervical Spine Mobilization on Lateral Epicondylitis

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

The study's primary goal is to examine the effectiveness of Mulligan's technique in reducing hyperalgesia in lateral epicondylitis, focusing on cervical spine, while also investigating its influence on central sensitization in relation to lateral epicondylitis.

NCT ID: NCT06267027 Completed - Clinical trials for Lateral Epicondylitis

Comparison of Different Physical Therapy Modalities in Lateral Epicondylitis

Start date: February 7, 2023
Phase: N/A
Study type: Interventional

Comparison of the effects of kinesiotaping and high intensity laser therapy in patients with lateral epicondylitis: a randomized controlled study

NCT ID: NCT06236178 Completed - Clinical trials for Lateral Epicondylitis

Comparing Autologous Blood, Corticosteroid, and Their Combined Injection for Treating Lateral Epicondylitis

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare autologous blood, corticosteroid, and their combined injection for treating lateral epicondylitis. The main question it aims to answer are: • Which of these highly used drugs in treatment of lateral epicondylitis is more effective? Participants were randomly allocated into three equal treatment groups (AB versus CS versus their combination) with sealed envelopes prepared by a computer-based random number generator. Patients in the AB Group received 1 ml of autologous venous blood mixed with 2 ml of 2% prilocaine HCl, patients in the CS Group received 1 ml of 40 mg methylprednisolone acetate mixed with 2 ml of 2% prilocaine HCl, and patients in the Combined Group (AB+CS) received 1 ml of autologous venous blood, 1 ml of 40 mg methylprednisolone acetate mixed with 1 ml of 2% prilocaine HCl. Each group received an equal amount of (3 ml) injected material. PRTEE and HGS measurements were assessed before the injection (baseline values), on Day 15, Day 30, and Day 90, in the same manner by the senior author.

NCT ID: NCT06221514 Recruiting - Tennis Elbow Clinical Trials

Effect of Core Versus on Tennis Serve Velocity in Young Adult Tennis Players

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to compare the effect of a 4-week core strengthening program on flat serve velocity in amateur young adult tennis players to a shoulder strengthening program. Participants will serve the tennis ball four times during the initial and final flat tennis serve assessments. Furthermore, participants will be divided into two groups and given different strengthening programs. Researchers will compare Group A (shoulder strengthening group) and Group B (core strengthening group) to see if there is any difference between the core and shoulder training programs on the flat serve velocity.

NCT ID: NCT06206109 Completed - Clinical trials for Lateral Epicondylitis

The Effect of Tendon Tears on Lateral Epicondylitis

Start date: September 13, 2023
Phase:
Study type: Observational

Common extensor tendon (CET) tears that can be detected with ultrasonography (US) may be associated with worsening clinical and other ultrasonographic parameters in patients with LE. In this retrospective evaluation of patients with lateral epicondylitis (LE), the effect of common extensor tendon (CET) tears revealed by ultrasonography (US) with demographic, clinical, and other US findings was investigated.

NCT ID: NCT06192927 Not yet recruiting - Tennis Elbow Clinical Trials

Efficacy and Safety of TenoMiR in Lateral Epicondylitis

Start date: January 2024
Phase: Phase 2
Study type: Interventional

This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of providing a more reliable treatment than those currently available and can be given at the time of first diagnosis, so that recovery can begin as soon as possible. The study drug has been tested in humans in an earlier study, and appeared to be safe and well-tolerated. This study aims to test the study drug in a larger number of participants.